The Hippo

HOME| ADVERTISING | CONTACT US|

Protein May Identify Deadlier Breast Cancer Manchester NH

A protein linked to more aggressive and advanced breast cancer tumors has been identified by German researchers. The investigators analyzed 229 breast tissue samples from patients with cancer and compared them with healthy breast tissue. The study found that patients whose tumors had elevated levels of GLI1 (glioma-associated oncogene homolog 1) protein tended to have a more advanced stage of cancer, had an increased number of cancerous lymph nodes and a greater chance of death.

South Willow Animal Hospital
(603) 641-6252
575 South Willow Street
Manchester, NH

Data Provided by:
Northside Animal Hospital
(603) 622-5299
574 Arah Street
Hooksett, NH

Data Provided by:
HealthSource of Londonderry
(603) 624-6100
298 Rockingham Road
Londonderry, NH

Data Provided by:
Derry Animal Hospital
(603) 432-3700
28 Tsienneto Road
Derry, NH

Data Provided by:
Pain Relief Center
(603) 886-4500
163 Amherst St
Nashua, NH

Data Provided by:
Daniel Webster Animal Hospital
(603) 624-4004
3 Hawthorne Dr.
Bedford, NH

Data Provided by:
Healing Hands Chiropractic Family Wellness Ce
(603) 434-3456
156 Harvey Rd
Londonderry, NH

Data Provided by:
Merrimack Veterinary Hospital
(603) 424-9922
235 Daniel Webster Hwy
Merrimack, NH

Data Provided by:
Ponemah Veterinary Hospital
(603) 673-5300
199 Rte 101
Amherst, NH

Data Provided by:
Hampstead Animal Hospital
(603) 329-7825
472 Route 111
Hampstead, NH

Data Provided by:
Data Provided by:

Protein May Identify Deadlier Breast Cancer

Provided By:

TUESDAY, Aug. 25 (HealthDay News) -- A protein linked to more aggressive and advanced breast cancer tumors has been identified by German researchers.

The investigators analyzed 229 breast tissue samples from patients with cancer and compared them with healthy breast tissue. The study found that patients whose tumors had elevated levels of GLI1 (glioma-associated oncogene homolog 1) protein tended to have a more advanced stage of cancer, had an increased number of cancerous lymph nodes and a greater chance of death.

GLI1 could be a useful measurement for determining cancer prognosis, according to the study published this week in the journal BMC Cancer.

"GLI1, a mediator of the so-called 'hedgehog' signaling pathway, has previously been implicated in the development of different human tumor entities," said lead study author Edgar Dahl of RWTH Aachen's University Hospital in Germany, in a news release from the journal's publisher.

"We've found a positive, significant association between overexpression of GLI1 and unfavorable overall survival outcome in human breast cancer," Dahl added.

Overexpression of GLI1 has also been implicated in esophageal cancer, the researchers noted.

"Taken together, these results support a role of GLI1 as a new prognostic biomarker in breast cancer," Dahl said. "Future studies will determine whether GLI1 can be successfully included into multimarker panels for early cancer detection or molecular sub-typing of breast cancer. This could support personalized breast cancer medicine."

More information

The American Cancer Society has more on breast cancer.

SOURCE: BioMed Central, news release, Aug. 24, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

®2010 Hippo Press. site by wedu